1031360-18-5
1031360-18-5
Chemical Structure
Sonepcizumab
Synonym(s): LT 1009; Anti-Human S1P Recombinant Antibody
- CAS No.: 1031360-18-5
- Formula:N/A
- Molecular Weight:(146.4 kDa)
IUPAC Name: N-(methyl-d3)ethanamine
SMILES: [Sonepcizumab]
Biological Activity: Sonepcizumab (LT 1009) is a fully human anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Sonepcizumab | 95.00% | Sonepcizumab (LT 1009) is a fully human anti-S1P monoclonal antibody. Sonepcizumab has the potential for the research of metastatic renal cell carcinoma (mRCC). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
